Świerczyńska, K.; Krajewski, P.K.; Nowicka-Suszko, D.; Białynicki-Birula, R.; Krajewska, M.; Szepietowski, J.C.
The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect? Toxins 2022, 14, 197.
https://doi.org/10.3390/toxins14030197
AMA Style
Świerczyńska K, Krajewski PK, Nowicka-Suszko D, Białynicki-Birula R, Krajewska M, Szepietowski JC.
The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect? Toxins. 2022; 14(3):197.
https://doi.org/10.3390/toxins14030197
Chicago/Turabian Style
Świerczyńska, Karolina, Piotr K. Krajewski, Danuta Nowicka-Suszko, Rafał Białynicki-Birula, Magdalena Krajewska, and Jacek C. Szepietowski.
2022. "The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect?" Toxins 14, no. 3: 197.
https://doi.org/10.3390/toxins14030197
APA Style
Świerczyńska, K., Krajewski, P. K., Nowicka-Suszko, D., Białynicki-Birula, R., Krajewska, M., & Szepietowski, J. C.
(2022). The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect? Toxins, 14(3), 197.
https://doi.org/10.3390/toxins14030197